Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Keeping tabs on pharma: Big pharma makes progress on ‘difficult-to-treat’ diseases and GHD patients receive new drug
August 31 by Adam JeffsPharma IQ dives into advancements made in the field of drug discovery over the last week
Keeping tabs on Covid-19: Big pharma’s response to the global health emergency
August 20 by Emily UwemedimoThe latest developments from Roche, Regeneron, AstraZeneca, Amgen and Merck as they progress with projects to tackle the Covid-19 pandemic
Keeping tabs on Pharma: Covid-19 booster shots on the agenda and medicinal research receives investment boost
August 13 by Adam JeffsCovid-19 booster shots could become a necessity and investment increases for medicinal research to meet patient needs
Keeping tabs on pharma: Sanofi stops clinical trial early after meeting survival endpoint and Bayer invests in crop protection to advance scientific innovation
August 06 by Emily UwemedimoBayer commits to crop protection innovation to advance health security following the Covid-19 pandemic
Keeping tabs on Covid-19: EMA approves Moderna vaccine for teens and Japan approves Roche–Regeneron’s treatment
July 30 by Emily UwemedimoThe EMA recommends Moderna’s Covid-19 vaccine for 12–17 year olds as discussions continue with the FDA for approval for children in the US
Keeping tabs on pharma: DeepMind’s AI predicts the human proteome and Russia joins the trend of providing real-world evidence for clinical trials
July 26 by Adam JeffsA decade of research has been surpassed in just 15 minutes by AI and the availability of real-world evidence for clinical trials continues to grow
Expert insights: How AI enhances drug discovery efforts
July 26 by Pharma IQExplore the growing role of data and AI in pharmaceutical drug discovery and development
Keeping tabs on Covid-19: Taiwan’s vaccine feud with China ends and South Africa registers more than 17,000 new Covid-19 cases
July 16 by Emily UwemedimoThe sharp rise in Covid-19 infections in Taiwan has renewed the debated on whether the island’s government should allow drug imports to resume from mainland China
Keeping tabs on pharma: Oxford HIV vaccine trial gets underway and Covid-19 data reveals men more likely to die from disease than woman
July 08 by Ben WattsThe latest update from the Pharma IQ team dives into news of a new HIV vaccine trial and the gender gap opening up in the US for vaccination rates
Keeping tabs on pharma: Push for Africa to localize its pharmaceutical development
July 02 by Emily UwemedimoDiscover how big pharma companies plan to support African nations via the continent’s first mRNA vaccine manufacturing hub
Keeping tabs on Covid-19: Japan declares state of emergency but plans for Olympics continue and initiative increases Covid-19 vaccine confidence in women of color
June 25 by Emily UwemedimoWomen of Color in Pharma creates "We Are Pharma” initiative to address Covid-19 vaccination concerns in minority communities
[Online Event] Pharma IQ LIVE: Transforming Drug Discovery through Artificial Intelligence – July 6th-8th
June 22 by Pharma IQDiscover the potential of AI to accelerate and reduce the cost of discovering new drugs